CSI Market
Sign In | Register

Catheter Precision Inc (VTAK) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access VTAK quarterly Cash Flow →
Cash flow performance over multiple periods helps investors evaluate the stability of Catheter Precision Inc's cash-generating activities.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
12 Months 		(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-17.70
Depreciation & amortization2.12
Amortization of Other Assets0.05
Accretion Expense0.00
Impairment of Intangible Assets, Finite-lived7.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-0.08
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.34
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction3.37
Accretion Of Royalties Payable-
Restructuring Costs And Assets Impairment Charges-
Fair Value Of Royalties Payable Increase Decrease-
Gain On Write Off Of Right Of Use Asset And Liability-
Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss-5.71
Property And Equipment Reclassified From Inventories0.03
Conversion Of Stock Amount Converted-
Noncash Or Part Noncash Acquisition Shares And Options Issued-
Deemed Dividend On Warrant Inducement Offer-
Increase Decrease In Operating Lease Liability0.00
Increase Decrease In Royalties Payable Current0.02
Increase Decrease In Contract With Customer Liability1.97
Increase Decrease In Contract With Customer Liability-
Increase Decrease In Contract With Customer Liability-
Increase Decrease In Contract With Customer Liability-
Income taxes-1.81
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.09
Increase (Decrease) in Accounts Payable1.16
Accrued Expense0.33
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets0.26
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.47
Discontinued operations0.00
Net Cash flow from Operating Activities-8.30
Investing Activities
Capital Expenditures-0.02
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities0.30
Short-term Investments Acq.0.00
Real Estate Investments0.00
Payment Of Fees Related To Sale Of Discontinued Operations-
Right Of Use Asset Obtained In Exchange For Operating Lease Liability-
Right Of Use Asset Obtained In Exchange For Operating Lease Liability-
Right Of Use Asset Obtained In Exchange For Operating Lease Liability-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired-0.12
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.17
Financing Activities
Short-term debt Net0.06
Other borrowing transactions0.00
Long-term debt - borrowings0.30
Long-term debt - repayments-0.24
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock1.17
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net3.75
Payments On Equipment Financing-
Payments For Restricted Stock Tax Liability On Settlement-
Proceeds From Issuance Of Common Stock And Warrants-
Proceeds From Issuance Of Common Stock And Warrants Net Of Placement Agent Fees-
Payments Of Offering Costs Related To Issuance Of Common Stock And Warrants-
Repayment Of Equipment Financing-
Proceeds From Issuance Of Common Stock And Warrants Net Fees Withheld-
Payments Of Convertible Promissory Notes-
Proceeds From The Private Placement Of Securities-
Payments Of Offering Costs Related To The Private Placement Of Securities-
Proceeds From Issuance Of Common Stock In Connection With The Employee Stock Purchase Plan-
Payments Of Costs Related To Exercise Of Warrants-
Proceeds From Issuance Of Convertible Note Payable0.30
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities5.34
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-8.31
Total Cash Flow-2.79
4 historic quarters locked

Sign in to unlock the full Catheter Precision Inc cash flow history.

Sign In Create Free Account

About Catheter Precision Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001437749-26-010549

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License